Skip to main content

Clinical trial AZUR-2 219606

A Phase 3, Double-Arm, Open-Label Study of Peri-operative Dostarlimab Monotherapy versus standard of care in Participants with Untreated Stage II/III dMMR/MSI-H

Organ Multiple
Trial status Trial open for recruitment
Trial type
Interventional with experimental drug
Phase Trial phase 3
Academic trial Non
Sponsor GSK
EudraCT Identifier 2023-503265-27-00
Last update